Purpose
Doctors and advanced practice providers may not be familiar with the risk factors, clinical presentation, methods for identification, or clinical management of Lymphocytic choriomeningitis (LCM). As cases of LCM persist in the U.S., it is important for medical staff, particularly transplant clinicians and obstetricians, to provide guidance on disease prevention, recognize LCM cases in their communities, and deliver critical care.
What you will learn
Lymphocytic choriomeningitis virus is a rodent-borne arenavirus with global distribution. LCM infection in humans is typically either asymptomatic or causes a mild influenza-like illness. In immunosuppressed individuals, like organ transplant recipients, infection can cause severe neurological disease, including meningitis and encephalitis, and can lead to death. Additionally, infection can be passed through the transplacental route leading to congenital abnormalities and spontaneous abortion.
This video provides an overview of lymphocytic choriomeningitis virus for clinicians in the U.S. Through this video, clinicians and health care providers will be given information on the clinical presentation and epidemiology of LCM in the U.S. They will also learn about high-risk groups, methods for disease prevention, and diagnostic testing of LCM.
By the end of this training, you will be able to:
- Describe LCM.
- Describe the epidemiology of LCM.
- Describe two methods for diagnosing a patient with LCM.
- Identify the parameters of clinical management for LCM.
- Describe my scope of practice as a team member when diagnosing or treating patients with lymphocytic choriomeningitis.
Training information
CE origination date: June 3, 2024
CE expiration date: June 3, 2026
Prerequisites: General knowledge of infectious diseases
Format: This activity is Web on Demand.
Contact Information: CDC's Viral Special Pathogens Branch (404) 639-1115
Instructions for obtaining Continuing Education (CE)
To receive continuing education (CE) for WD4852- Lymphocytic Choriomeningitis Virus: Information for Medical Providers, please visit CDC TRAIN and search for the course in the Course Catalog using WD4852. Follow the steps below by June 03, 2026.
- Register for and complete the course.
- Pass the post-assessment at 80%.
- Complete the evaluation.
- Visit Your Learning to access your certificates and transcript.
No fees are charged for CDC's CE activities.
Accreditation statement
In support of improving patient care, The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME: The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention designates this activity for 0.25 nursing contact hours.
Disclosure: In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies during the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.
CDC, our planners, and content experts wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.